EUVIMEDEUVIMED entdecken
Open Access

Successful completion of large, low-cost randomized cancer trials at an academic cancer center

Andrew J Vickers iD, Behfar Ehdaie, Hanae K Tokita iD, Jonas Nelson, Evan Matros, Andrea L Pusic, Michael D'Angelica

Clinical Trials · 2025

DOI: 10.1177/17407745241284044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Trials, 2025. Verfasst von Andrew J Vickers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Neoplasms, Academic Medical Centers, Cancer Care Facilities. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, national cancer institute, sidney kimmel center for prostate and urologic cancers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concerns about low accrual have long been a standard part of the discourse on cancer clinical trials, reaching even as far as the news media. Indeed, so many trials are closed before completing accrual that a cottage industry has recently developed creating statistical models to predict trial failure. We previously proposed four methodologic fixes for the current crisis in clinical trials: (1) dramatically reducing the number of eligibility criteria, (2) using data routinely collected in clinical practice for trial endpoints; then lowering barriers to accrual by (3) cluster randomization or (4) staged consent.

Methods

We report our practical experience of applying these fixes to randomized trials at Memorial Sloan Kettering Cancer Center.

Results

We have completed seven single-center randomized trials, with several more underway and accruing rapidly, with a total accrual approaching 10,000. Many of the trials have compared surgical interventions, an area where trials have traditionally been hard to complete. Only one of these trials was externally funded. While low costs were possible due to the existing research infrastructure at our institution, such infrastructure is common at major cancer centers.

Conclusions

Further research on innovative clinical trial designs is warranted, particularly in higher-stakes settings, and in trials of medical and radiotherapy interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicNeoplasmsAcademic Medical CentersCancer Care FacilitiesHumansPatient SelectionResearch Design

Stichwörter der Autor:innen

Clinical trialscancercluster randomizationconsentsurgery research

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Anesthesiology and Critical Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Boston, MA, USA.

ORCID-Profile: Andrew J Vickers, Hanae K Tokita

Förderung

  • NCI NIH HHS
  • national cancer institute
  • sidney kimmel center for prostate and urologic cancers

Zitieren

APA

Vickers, A. J., Ehdaie, B., Tokita, H. K., Nelson, J., Matros, E., Pusic, A. L., & D'Angelica, M. (2025). Successful completion of large, low-cost randomized cancer trials at an academic cancer center. Clinical Trials. https://doi.org/10.1177/17407745241284044

Vancouver

Vickers AJ, Ehdaie B, Tokita HK, Nelson J, Matros E, Pusic AL, et al. Successful completion of large, low-cost randomized cancer trials at an academic cancer center. Clinical Trials. 2025. doi:10.1177/17407745241284044

BibTeX
@article{Vickers2025,
  author = {Vickers, Andrew J and Ehdaie, Behfar and Tokita, Hanae K and Nelson, Jonas and Matros, Evan and Pusic, Andrea L and D'Angelica, Michael},
  title = {Successful completion of large, low-cost randomized cancer trials at an academic cancer center},
  journal = {Clinical Trials},
  year = {2025},
  doi = {10.1177/17407745241284044}
}
Kostenlos starten →